TruBridge (TBRG) 2025 Conference Summary Company Overview - TruBridge has been in operation since 1979, focusing on serving the rural and community healthcare market through two main business units: Electronic Health Records (EHR) and Revenue Cycle Management (RCM) [4][5] - The EHR business targets hospitals with 100 beds and under, while the RCM business serves hospitals with 400 beds and under [4] Core Business Strategy - The company emphasizes its commitment to the rural community market, believing it is underserved and presents economic opportunities [5] - TruBridge aims to keep its technology updated and expand services to enhance patient care delivery for its customers [6] Recent Developments - The annual client conference focused on EHR customers, showcasing technological innovations and gathering feedback on challenges faced by clients [7] - A partnership with Microsoft to leverage Azure for cloud technology has been established, enhancing service delivery [8] Market Conditions - Concerns about the rural hospital market include reports that 40% are on the verge of closure; however, the company argues that similar issues exist in larger hospitals [12] - The company plays a role in improving efficiency in patient care delivery and backend processes to ensure steady cash flow for rural hospitals [14] Competitive Landscape - TruBridge differentiates itself by focusing solely on the rural community market, unlike larger competitors such as Cerner and Epic, which target larger hospitals [15][16] - The company believes it can create value through its combined EHR and RCM services, which are tailored for rural hospitals [18] Automation and AI Initiatives - Investments in automation and standardization are aimed at improving efficiency in RCM and EHR processes, including the use of robotic process automation [19][20] - The goal is to reduce provider burnout by streamlining documentation processes, allowing healthcare providers to spend more time with patients [21] Financial Performance - TruBridge has shown strong financial results, exceeding consensus estimates in five consecutive quarters [25] - The company reported an EBITDA margin of approximately 11-12% in Q1 2024, with a focus on cash management leading to a reduction in debt by $26 million [26] Future Guidance - The company aims for a long-term EBITDA margin target of 20% by the end of 2024, with aspirations to reach 25% and then 30% in subsequent years [33][34] - Economic uncertainties may impact guidance, but the company remains optimistic about its financial health and growth potential [28] SaaS Model Transition - TruBridge is transitioning its EHR business from a licensed model to a Software as a Service (SaaS) model, which is more appealing to customers due to predictable costs [39][40] - The company has seen nearly 100% of new EHR customers adopt the SaaS model, indicating a shift in customer preferences [41] Reimbursement Environment - The reimbursement landscape for rural hospitals remains uncertain, with potential impacts from Medicaid and Medicare changes [35][36] - TruBridge aims to help hospitals navigate these challenges by providing RCM solutions to stabilize their financial health [37] Underappreciated Aspects - The company is shifting from a lifestyle company to a performance-driven organization, focusing on seizing market opportunities and enhancing financial performance [49] Conclusion - TruBridge is strategically positioned to serve the rural healthcare market with a focus on technology and service delivery, while navigating financial and operational challenges in a changing healthcare landscape.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41992 TRUBRIDGE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 74-3032373 (State or Other Jurisdiction of Incorporatio ...

TruBridge (TBRG) came out with quarterly earnings of $0.36 per share, missing the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.19 per share a year ago. These figures are adjusted for non- recurring items. TruBridge shares have added about 29.1% since the beginning of the year versus the S&P 500's decline of -4.7%. What's Next for TruBridge? While TruBridge has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? ...

TruBridge (TBRG) Q1 2025 Earnings Call May 07, 2025 04:30 PM ET Company Participants Dru Anderson - Senior PartnerChris Fowler - President & CEOVinay Bassi - Chief Financial OfficerJeff Garro - Managing Director Conference Call Participants Sarah James - Managing Director & Equity Analyst - Healthcare Services & HCITGene Mannheimer - Managing Director, Senior Research Analyst Operator Good afternoon, ladies and gentlemen, and welcome to TruBridge First Quarter Earnings Conference Call. This call is being re ...

TruBridge (TBRG) Q1 2025 Earnings Call May 07, 2025 04:30 PM ET Speaker0 Good afternoon, ladies and gentlemen, and welcome to TruBridge First Quarter Earnings Conference Call. This call is being recorded on Wednesday, 05/07/2025. I would now like to turn the conference over to Drew Anderson. Please go ahead. Speaker1 Thank you. Good afternoon, and welcome to the TruBridge first quarter twenty twenty five earnings conference call. Leading today's call are Chris Fowler, President and Chief Executive Officer a ...

Exhibit 99.1 TRUBRIDGE ANNOUNCES FIRST QUARTER 2025 RESULTS MOBILE, ALA. (May 7, 2025) – TruBridge, Inc. (NASDAQ: TBRG), a healthcare solutions company, today announced financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights* All comparisons are to the quarter ended March 31, 2024, unless otherwise noted *As of the third quarter of 2024, TruBridge is now reporting two segments in its financial statements representing the two business units. Financial Health represents the ...

Financial Performance - The company reported a significant increase in revenue, achieving $1.2 billion, representing a 15% year-over-year growth[7]. - Operating margins improved to 25%, up from 22% in the previous year, reflecting better cost management[7]. - The company anticipates a revenue growth of 10% to 12% for the next fiscal year, driven by new product launches and market expansion[7]. User Engagement - User data showed a 25% increase in active users, reaching 5 million, indicating strong market engagement[7]. - The backlog of orders increased by 18%, indicating strong demand for the company's services[7]. Market Expansion - The company plans to expand its market presence in Europe, targeting a 30% increase in market share over the next two years[7]. - A strategic acquisition was completed, valued at $200 million, aimed at enhancing product offerings and customer base[7]. Investment in Technology - Investment in new technology development increased by 20%, focusing on enhancing software capabilities and security features[7]. - The company is committed to maintaining its R&D spending at 15% of total revenue to drive innovation[7]. Revenue Model Transition - The company is transitioning to a subscription-based revenue model, which is expected to improve cash flow stability[7].

Financial Data and Key Metrics Changes - In Q4 2024, the company reported revenue of $87.4 million, an increase of 2% year-over-year, and adjusted EBITDA of $17.2 million, which was an increase of 44% compared to the previous year [8][49]. - For the full year 2024, total revenue was $339 million, with adjusted EBITDA of $53 million, exceeding the high end of guidance [10][58]. - Cash flow from operations improved to $32 million from just over $1 million in the previous year, with Q4 cash flow from operations at $10.3 million, a $23 million improvement year-over-year [10][38]. Business Line Data and Key Metrics Changes - Financial Health revenue for Q4 was $54.7 million, up 7.3% year-over-year, representing approximately 63% of total revenue [49]. - Patient Care revenue decreased by 6.3% year-over-year to $32.7 million, primarily due to the impact of revenues from ESG and Centriq in Q4 2023 [50]. - Total bookings for the year were $82 million, reflecting a 2.3% increase compared to the prior year, with Financial Health bookings flat and Patient Care bookings up 6% [54][56]. Market Data and Key Metrics Changes - The company noted that the market for hospitals with 100 to 400 beds grew from 5% to over 20% of financial health opportunities in their pipeline from 2023 to 2024 [16]. - The company is focusing on expanding its presence in this market segment, which is expected to drive future growth [16]. Company Strategy and Development Direction - The company plans to continue improving customer satisfaction and retention, as well as increasing profitability and growth in 2025 [18][32]. - A new leadership appointment in the Financial Health business unit aims to enhance customer satisfaction and pipeline expansion [19][20]. - The company is also focusing on optimizing its operations and capital allocation, with a goal of reducing its net leverage ratio to 2.5 times [40]. Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the future, despite some uncertainty regarding healthcare funding from the government, which could impact deal timing [13][106]. - The company is committed to maintaining momentum from 2024 into 2025, with expectations of mid-single-digit revenue growth and EBITDA margins in the mid-20s [32][60]. Other Important Information - The company has made significant improvements in cash flow management and working capital, with a focus on accounts receivable and collections [38][47]. - The company has also rationalized its capital expenditures, reducing its capitalized software as a percentage of total revenue [43][44]. Q&A Session Summary Question: Can you speak to the visibility on closing the remaining deals expected to close in Q4 2024? - Management indicated that while some deals slipped, they expect to close them in the first half of 2025, citing external factors affecting customer decisions [64][66]. Question: What are the expectations for sales and marketing initiatives in 2025? - The company plans to increase investments in marketing to enhance brand exposure, particularly among hospitals that do not currently use their technology [68][70]. Question: How does the company view the growth among its two segments for 2025? - Financial Health is expected to be the primary growth driver, while Patient Care is anticipated to see low single-digit growth [85][87]. Question: Can you provide insights on the demand environment and secondary metrics like pipeline and win rate? - Management noted that about 40% of bookings in a quarter are opportunities that opened and closed within that quarter, and the win rate is above 50% when excluding no-decision outcomes [89][95]. Question: How does the company plan to handle the 60 key CBO client renewals in the next 24 months? - Management emphasized a focus on customer satisfaction to ensure high retention rates among these clients, with no outsized clients among them [99][102].

TruBridge, Inc. (NASDAQ:TBRG) Q4 2024 Earnings Conference Call March 10, 2025 4:30 PM ET Company Participants Dru Anderson - IR Chris Fowler - President and CEO Vinay Bassi - CFO Conference Call Participants Sean Dodge - RBC Capital Markets Jeff Garro - Stephens Inc George Hill - Deutsche Bank Gene Mannheimer - Freedom Capital Markets Operator Greetings, and welcome to the TruBridge Q4 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session wil ...

Revenue Performance - Revenue for 2024 was $339.2 million, with Q4 revenue at $87.4 million, representing a slight decrease from $339.4 million in 2023[5]. - Financial Health revenue for 2024 was $216.1 million, accounting for 63.7% of total revenue, compared to $193.9 million in 2023[11]. - Total annual bookings reached $82.1 million, up from $80.2 million in 2023[11]. - TruBridge's total revenue from the Financial Health segment for the twelve months ended December 31, 2024, was $34,559,000, up from $24,800,000 in 2023, reflecting a growth of approximately 39%[26]. - Total bookings for the twelve months ended December 31, 2024, were $82,074,000, up from $80,239,000 in 2023, showing a growth of about 2%[21]. Profitability and Loss - Net loss for 2024 was $23.1 million, with a Q4 net loss of $5.7 million, compared to a net loss of $42.5 million in Q4 2023[6]. - TruBridge reported a net loss of $23,084,000 for the twelve months ended December 31, 2024, an improvement from a net loss of $45,789,000 in 2023, indicating a reduction of 49% year-over-year[19]. - For the three months ended December 31, 2024, the company reported a non-GAAP net income of $715,000, compared to $5,129,000 in the same period of 2023, representing a decrease of approximately 86%[30]. - The non-GAAP EPS for the twelve months ended December 31, 2024, was $0.24, down from $1.79 in 2023, indicating a decline of about 87%[30]. Adjusted EBITDA and Margins - Adjusted EBITDA for 2024 was $53.1 million, with Q4 adjusted EBITDA at $17.2 million, an increase from $12.0 million in Q4 2023[6]. - Adjusted EBITDA for the twelve months ended December 31, 2024, was $53,090,000, compared to $47,576,000 in 2023, marking an increase of approximately 11%[28]. - The company’s adjusted EBITDA margin improved to 15.7% in 2024 from 14.0% in 2023[28]. Operational Efficiency - The company transitioned approximately 30% of its Financial Health Complete Business Office client base offshore, improving operational efficiency[5]. - The leverage ratio improved from 4x at the end of 2023 to approximately 3x at the end of 2024 due to significant debt repayment[5]. Assets and Liabilities - Total current assets decreased to $90,274,000 in 2024 from $111,455,000 in 2023, representing a decline of approximately 19%[17]. - Total liabilities decreased to $225,737,000 in 2024 from $247,804,000 in 2023, reflecting a reduction of about 9%[17]. - The company’s total stockholders' equity decreased to $168,695,000 in 2024 from $186,618,000 in 2023, a decline of approximately 10%[17]. - Cash and cash equivalents increased to $12,324,000 at the end of 2024 from $3,848,000 at the end of 2023, representing a significant increase of 221%[19]. Strategic Initiatives - The company divested American Health Tech, marking its first divestiture in history, as part of its strategic initiatives[5]. - The provision for expected credit losses increased to $3,669,000 in 2024 from $1,920,000 in 2023, indicating a rise of 91%[19]. - The company plans to focus on strategic planning and operational performance evaluation using non-GAAP financial measures to better understand ongoing business trends[33]. - Management emphasizes that non-GAAP financial measures are important indicators of operational strength and should be considered alongside GAAP measures for a comprehensive view of financial performance[39]. Revenue Breakdown - Total Patient Care revenues for the twelve months ended December 31, 2024, were $123,098,000, a decrease of 15.4% from $145,506,000 in 2023[32]. - Recurring revenues from Acute Care for the three months ended December 31, 2024, were $28,193,000, slightly down from $28,640,000 in the same period of 2023[32]. - Non-recurring revenues from Acute Care increased to $4,515,000 for the three months ended December 31, 2024, compared to $2,447,000 in 2023, marking an increase of approximately 84.5%[32]. Other Financial Adjustments - The company incurred a pre-tax adjustment of $2,993,000 for severance and other nonrecurring charges in the three months ended December 31, 2024[30]. - The amortization of acquisition-related intangible assets for the twelve months ended December 31, 2024, was $12,505,000, down from $16,426,000 in 2023, reflecting a decrease of about 23.5%[30]. - The weighted average shares outstanding, diluted, increased to 14,330,000 for the three months ended December 31, 2024, compared to 14,205,000 in the same period of 2023[30].